Siegler, J., Correia, M., Hofman, T., Prager, I., Birgin, E., Rahbari, N. N., . . . Cerwenka, A. (2022). Human ILC3 exert TRAIL-mediated cytotoxicity towards cancer cells. Frontiers in immunology, 13, . https://doi.org/10.3389/fimmu.2022.742571
Chicago-Zitierstil (17. Ausg.)Siegler, Jana-Julia, Margareta Correia, Tomáš Hofman, Isabel Prager, Emrullah Birgin, Nuh Nabi Rahbari, Carsten Watzl, Ana Stojanovic, und Adelheid Cerwenka. "Human ILC3 Exert TRAIL-mediated Cytotoxicity Towards Cancer Cells." Frontiers in Immunology 13 (2022). https://doi.org/10.3389/fimmu.2022.742571.
MLA-Zitierstil (9. Ausg.)Siegler, Jana-Julia, et al. "Human ILC3 Exert TRAIL-mediated Cytotoxicity Towards Cancer Cells." Frontiers in Immunology, vol. 13, 2022, https://doi.org/10.3389/fimmu.2022.742571.